Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,303.10 +8.60 0.06%
S&P 500 1,649.60 -0.91 -0.06%
Nasdaq 3,459.14 -0.27 -0.01%
Ticker Volume Price Price Delta
STOXX 50 2,764.29 -12.49 -0.45%
FTSE 100 6,654.34 -42.45 -0.63%
DAX 8,305.32 -46.66 -0.56%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,618.70 -51.01 -0.23%
S&P/ASX 200 4,983.50 -78.95 -1.56%
  • Fund Type: Open-End Fund
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: China

China Universal Health Care Equity Fund

+ Add to Watchlist

CHUHCEF:CH

1.12 CNY 0.02 1.36%

As of 11:56:56 ET on 05/24/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for China Universal Health Care Equity Fund (CHUHCEF)

Year To Date: +27.05% 3-Month: +8.86% 3-Year: - 52-Week Range: 0.77 - 1.12
1-Month: +6.37% 1-Year: +42.78% 5-Year: - Beta vs : -

Mutual Fund Chart for CHUHCEF

No chart data available.
  • CHUHCEF:CH 1.12
  • 1M
  • 1Y
Interactive CHUHCEF Chart

Previous Close

Fund Profile & Information for CHUHCEF

China Universal Health Care Equity Fund is an open-end fund incorporated in China. The Fund's objective is to utilize a bottom-up strategy to obtain medium- to long-term stable returns. The Fund invests at least 80% of its assets in the equities of health-care companies listed in China.

Inception Date: 09-30-2010 Telephone: 86-21-2893-2888 Tel
Managers: WANG XU
Web Site: www.htffund.com

Fundamentals for CHUHCEF

NAV (on 2013-05-24) 1.12
Assets (M) (on 2013-03-31) 3,111.99
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 1,000.00

Dividends for CHUHCEF

No dividends reported

Fees & Expenses for CHUHCEF

Front Load 1.50
Back Load 0.50
Current Mgmt Fee 1.50
Redemption Fee 0.50
12b1 Fee -
Expense Ratio -

Top Fund Holdings for CHUHCEF

Filing Date: 12/31/2012
Name Position Value % of Total
Tasly Pharmaceutical Group Co 6,799,760 187,911,368 7.219%
Humanwell Healthcare Group Co 7,931,945 185,528,194 7.127%
Hualan Biological Engineering 5,684,282 119,597,293 4.594%
Jiangsu Kanion Pharmaceutical 5,052,700 105,096,160 4.037%
ADBCH 3.76 07/13/19 100,000 97,330,000 3.739%
China Resources Sanjiu Medical 3,842,883 91,076,327 3.499%
Zhejiang Huahai Pharmaceutical 10,085,427 88,441,439 3.398%
Guizhou Yibai Pharmaceutical C 4,339,742 86,838,237 3.336%
Jiangsu Hengrui Medicine Co Lt 2,800,000 84,280,000 3.238%
Yunnan Baiyao Group Co Ltd 1,200,000 81,600,000 3.135%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil